JPS53105475A - Pyrolidine derivative - Google Patents

Pyrolidine derivative

Info

Publication number
JPS53105475A
JPS53105475A JP2082078A JP2082078A JPS53105475A JP S53105475 A JPS53105475 A JP S53105475A JP 2082078 A JP2082078 A JP 2082078A JP 2082078 A JP2082078 A JP 2082078A JP S53105475 A JPS53105475 A JP S53105475A
Authority
JP
Japan
Prior art keywords
pyrolidine
derivative
pyrolidine derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2082078A
Other languages
English (en)
Other versions
JPS5516577B2 (ja
Inventor
Barugi Rasuzuro
Ugon Pieeru
Deyuhauruto Jiyatsuku
Burangeeru Mishieru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Science Union et Cie
Original Assignee
Science Union et Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union et Cie filed Critical Science Union et Cie
Publication of JPS53105475A publication Critical patent/JPS53105475A/ja
Publication of JPS5516577B2 publication Critical patent/JPS5516577B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2082078A 1977-02-25 1978-02-24 Pyrolidine derivative Granted JPS53105475A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8096/77A GB1561411A (en) 1977-02-25 1977-02-25 2-phenoxyphenyl pyrrolidines and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
JPS53105475A true JPS53105475A (en) 1978-09-13
JPS5516577B2 JPS5516577B2 (ja) 1980-05-02

Family

ID=9845699

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2082078A Granted JPS53105475A (en) 1977-02-25 1978-02-24 Pyrolidine derivative

Country Status (21)

Country Link
US (1) US4161529A (ja)
JP (1) JPS53105475A (ja)
AT (1) ATA128978A (ja)
AU (1) AU3355278A (ja)
BE (1) BE864312A (ja)
CA (1) CA1101872A (ja)
CH (1) CH631162A5 (ja)
DD (1) DD134088A5 (ja)
DE (1) DE2807623C2 (ja)
ES (1) ES467286A1 (ja)
FR (1) FR2381753A1 (ja)
GB (1) GB1561411A (ja)
GR (1) GR63171B (ja)
IN (1) IN147858B (ja)
NL (1) NL7802069A (ja)
NZ (1) NZ186552A (ja)
OA (1) OA05895A (ja)
PH (1) PH13661A (ja)
PT (1) PT67698B (ja)
YU (1) YU33278A (ja)
ZA (1) ZA781100B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004524261A (ja) * 2000-06-07 2004-08-12 ブリストル−マイヤーズ　スクイブ　カンパニー 甲状腺受容体に対するベンザミドリガンド

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6080872U (ja) * 1983-11-11 1985-06-05 日立工機株式会社 クラツチ式締付工具
JPS60108826A (ja) * 1983-11-18 1985-06-14 Ricoh Co Ltd 自動露出制御回路
JPS6165432U (ja) * 1984-10-02 1986-05-06
ZA923283B (en) * 1991-05-29 1993-01-27 Akzo Nv Phenoxyphenyl derivatives
US5665754A (en) * 1993-09-20 1997-09-09 Glaxo Wellcome Inc. Substituted pyrrolidines
US5578639A (en) * 1994-07-01 1996-11-26 Warner-Lambert Company PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption
YU56301A (sh) * 1999-02-23 2004-05-12 Pfizer Products Inc. Inhibitori resorpcije monoamina za tretiranje poremećaja cns
US6410736B1 (en) 1999-11-29 2002-06-25 Pfizer Inc. Biaryl ether derivatives useful as monoamine reuptake inhibitors
US6448293B1 (en) 2000-03-31 2002-09-10 Pfizer Inc. Diphenyl ether compounds useful in therapy
US6610747B2 (en) 2000-08-31 2003-08-26 Pfizer Inc. Phenoxybenzylamine derivatives as SSRIs
US6630504B2 (en) 2000-08-31 2003-10-07 Pfizer Inc. Phenoxyphenylheterocyclyl derivatives as SSRIs
US6436938B1 (en) * 2001-01-22 2002-08-20 Pfizer Inc. Combination treatment for depression
US20020123490A1 (en) * 2001-03-01 2002-09-05 Pfizer Inc. Combination treatment for anxiety, depression, obsessive compulsive disorder and psychosis
CA2509605C (en) 2002-12-13 2010-10-05 Warner-Lambert Company Llc Alpha-2-delta ligand to treat lower urinary tract symptoms
KR20090092307A (ko) 2006-12-22 2009-08-31 레코르다티 아일랜드 리미티드 하요도 장애에 대한 α2δ 리간드 및 ＮＳＡＩＤｓ의 복합 치료

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004524261A (ja) * 2000-06-07 2004-08-12 ブリストル−マイヤーズ　スクイブ　カンパニー 甲状腺受容体に対するベンザミドリガンド

Also Published As

Publication number Publication date
DE2807623A1 (de) 1978-08-31
OA05895A (fr) 1981-05-31
US4161529A (en) 1979-07-17
ATA128978A (de) 1980-07-15
GB1561411A (en) 1980-02-20
DE2807623C2 (de) 1982-07-01
FR2381753B1 (ja) 1979-07-13
GR63171B (en) 1979-09-28
DD134088A5 (de) 1979-02-07
CA1101872A (fr) 1981-05-26
BE864312A (fr) 1978-08-24
ES467286A1 (es) 1978-10-16
PH13661A (en) 1980-08-26
CH631162A5 (fr) 1982-07-30
JPS5516577B2 (ja) 1980-05-02
AU3355278A (en) 1979-08-30
PT67698B (en) 1979-07-25
ZA781100B (en) 1979-01-31
IN147858B (ja) 1980-07-19
NZ186552A (en) 1979-08-31
PT67698A (en) 1978-03-01
YU33278A (en) 1982-10-31
FR2381753A1 (fr) 1978-09-22
NL7802069A (nl) 1978-08-29

Similar Documents

Publication Publication Date Title
JPS5390251A (en) Hexahydroterphenyl derivative
AU4113878A (en) 1-alkanoyl-proline derivatives
JPS53105475A (en) Pyrolidine derivative
GB1557019A (en) Metalsulphonamido-benzamide derivatives
JPS5392786A (en) Novel aminoalkoxyphenyl derivative
HK18883A (en) Pyridine derivative
JPS5492974A (en) 44aminoquinoline derivative
JPS5473779A (en) 22iminooimidazolidine derivative
JPS5398993A (en) Oxadiazoropyrimidine derivative
AU3888578A (en) 4-hydroxy-2-benzimidazolinone derivatives
JPS5448751A (en) 255alkylcholesterol derivative
JPS5398992A (en) Oxadiazoropyrimidine derivative
JPS5387367A (en) Piperidine derivative
JPS543030A (en) Trioxyacylophenone derivative
JPS53108935A (en) 22hydroxyynnpropylamine derivative
GB2008582B (en) Pyridine derivative
JPS549243A (en) Ll or dllphenylglycine derivative
AU3313978A (en) Everninomicin derivatives
GB2003479A (en) 3-amino-17alpha-aza-d-homoandrostane derivatives
JPS5424884A (en) Tetrahydroosstriazinethione derivative
JPS545954A (en) 155substituteddomegaa pentanoylprostaglandin derivative
JPS53105486A (en) Pyridyllpiperazine derivative
JPS5432495A (en) Benzoobisthiazole derivative
GB2000769B (en) 4 - homoisotwistane derivatives
JPS5444651A (en) Diisubstituteddindene derivative